To Interventional Cardiology Program Directors and Education Coordinators:
 
We have an unexpected opening for our Mayo Clinic Interventional Cardiology Fellowship in Structural Heart Disease for 2024-25 in Rochester, Minnesota.

Second time #TAVI (TAV-in-TAV) is a challenging procedure😬! Interviewed by Alessandro Beneduce here at #PCRLV Vinayak Bapat explained why and how specific tools can help you in your clinical practice ⤵️

Transcatheter Aortic Valve Implantation in Mixed Aortic Valve Disease: A Multicenter Study sciencedirect.com/science/articl…

American Journal of Cardiology Raviteja R. Guddeti Andrew M. Goldsweig, MD, MS Sidakpal Panaich Jai Parekh Arav Jhand

Think non-dominant RCA occlusions are benign ? Think twice.
Read our case report on non-dominant RCA occlusion that led to VF arrest. Great work by Asim Shabbir, MD and excellent mentorship by Poonam Velagapudi

The first year of our new journal, MyJSCAI was extremely successful! Below are the top 5 downloaded articles in 2022. You can view these articles and others by visiting jscai.org.

Association between surgical risk & 30‐day stroke after TAVR vs. SAVR: meta‐analysis.

23 studies, 14,589 TAVR, 11,681 SAVR. TAVR a/w reduction in stroke risk, odds ratio 0.78.

onlinelibrary.wiley.com/doi/full/10.10…

Follow @CCIJournal, facebook.com/CCIJournal
Official Journal of SCAI Now

Pulmonary vein stenosis can arise from several etiologies, including congenital, acquired & iatrogenic sources. PVS presents insidiously, leading to significant delays in diagnosis. Read more on PVS in #JACC : bit.ly/3CvKapJ

Many many congratulations to Dr Jason Sims, Dr Michael Sabbah and John Nan on successfully completing interventional cardiology and structural heart disease training Mayo Clinic CV

You all have been incredible role models. Mayo cath lab will miss you.

A very timely comprehensive review on evaluation and management of PV stenosis led by Trevor Simard

Excellent case series led by ⭐️ fellow Kristen N. Brown, MD🫀 just published in European Society of Cardiology Journals.
EHJCaseReports Editor-in-Chief Andrew M. Goldsweig, MD, MS Yiannis Chatzizisis

Dr. Gary Roubin presented a very special gift following his presentation at #SCAI2023 as a tribute to the officers and members of SCAI, past and present, who have continued Andreas Gruentzig’s Mission of Patient Care, Innovation and Science in #InterventionalCardiology .

Truly a great honor and an excellent learning opportunity for me !

Many congratulations to my mentor, the dynamic and inspirational Andrew M. Goldsweig, MD, MS for being the recipient of SCAI Now Early career research grant. Very well deserved !!

Standing room only! Excellent talk by Dr Chatzizisis on algorithmic approach to bifurcation PCI. #SCAI2023 #SCAIBifurcationClub

Have you met Dr. Yiannis Chatzizisis, UHealth’s Chief of Cardiovascular Medicine? Dr. Chatzizisis brings deep #leadership , #ClinicalResearch , and teaching experience to Miller Medicine. Learn more: loom.ly/Ab07X8c

Intriguing !

Left Main Perf
Papyrus covered stent into LAD
Cx Rescue

Some observations - brief thread 1/4

What a legend!! Learned so much from him in a small period of time. Happy retirement!

🚨Check out our pooled analysis of #MViV outcomes in patients with failed mitral bioprostheses

Mayra Guerrero, MD Sachin Goel Yehia Saleh Mayo Clinic CV #CardioTwitter

jscai.org/article/S2772-…

Bivalirudin vs. heparin during PCI in STEMI? The 2 best regimens (biv + high-dose post-PCI infusion) vs heparin alone (w/o routine GPI) have not been compared in a powered RCT. That changes Sunday at AHA - I'll be presenting BRIGHT-4, a 6016-pt RCT in STEMI w/radial access.